Erin M. Wessling - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: EVP & Chief Legal Officer
Issuer ticker: ELV
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 16:59:45 UTC
Prior SEC filing: 05 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Erin M. Wessling filed Form 4 for Elevance Health, Inc. (ELV) on 04 Mar 2026.

Key facts

This page summarizes Erin M. Wessling's Form 4 filing for Elevance Health, Inc. (ELV).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 16:59.

Change

Previous filing in this sequence was filed on 05 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002084548 Primary reporting owner

Wessling Erin M

Relationship: EVP & Chief Legal Officer
Address: 220 VIRGINIA AVENUE, INDIANAPOLIS
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Award

Transaction value
Shares: +2,976
Change %: +59%
Price: $0.000000^*
Shares after: 7,996
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

ELV transaction

Common Stock

Tax liability

Transaction value
Shares: -417
Change %: -5.2%
Price: $284.03^*
Shares after: 7,579
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELV transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +11,754
Change %
Price: $0.000000^*
Shares after: 11,754
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,754
Exercise price: $294.07
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.

Footnote F2

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Footnote F3

The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.